Почечно-клеточный рак у пациентов, находящихся на диализе

Почечно-клеточный рак у пациентов, находящихся на диализе

Автор: Isao Ishikawa

Журнал: Злокачественные опухоли @malignanttumors

Рубрика: Лекции

Статья в выпуске: 1 т.1, 2011 года.

Бесплатный доступ

Заболеваемость почечно-клеточным раком (ПКР) у пациентов, находящихся на диализе, выше, чем в общей популяции. Чем дольше больной получает гемодиализ, тем выше заболеваемость ПКР. Риск развития ПКР связан с формированием поликистоза почек. Некоторые виды ПКР у пациентов, находящихся на гемодиализе, или пациентов с заболеваниями почек поздних стадий не соответствуют гистологической классификации ПКР, представленной Всемирной Организацией Здравоохранения. Такие опухоли отличаются от спорадических; их называют ПКР, ассоциированным с приобретенным поликистозом почек (ППКП), или светлоклеточным-папиллярным ПКР у пациентов с заболеваниями почек поздних стадий. Рак почки на фоне ППКП развивается у пациентов, которые получают диализ длительно (более 10 лет). В связи с высокой заболеваемостью и отсутствием симптомов, пациентов находящихся на диализе из группы высокого риска, необходимо обследовать на предмет ПКР. Такой скрининг особенно важен для пациентов на диализе продолжительностью более 10 лет, пациентам с тяжелым ППКП и кандидатам на трансплантацию почки. Опухоль в почке, прилежащая к множественным приобретенным кистам, как правило, мало или совсем не накапливает контрастное вещество при КТ, а также не выступает за контур почки. Таким образом, дооперационная оценка ПКР у пациентов на длительном диализе затруднительна.

Еще

Приобретенные кисты почек, гемодиализ, почечно-клеточный рак, пкр на фоне ппкп, ультразвуковое исследование с контрастированием с использованием перфторбутановых микропузырь- ков, пэт-кт, кт

Короткий адрес: https://sciup.org/14045401

IDR: 14045401

Список литературы Почечно-клеточный рак у пациентов, находящихся на диализе

  • Ishikawa I: Acquired Cystic Disease of the Kidney and Renal Cell Carcinoma-Complication of Long-Term Hemodialysis, Springer,Tokyo. 1-111, 2007
  • Ishikawa I, Saito Y, Onouchi Z, Kitada H, Suzuki S, Kurihara S, Yuri T, Shinoda A: Development of acquired cysti disease and adenocarcinoma of the kidney in glomerulonephriti chronic hemodialysis pati nts. Clin Nephrol 14: 1-6, 1980
  • Ishikawa I, Onouchi Z, Saito Y, Tateishi K, Shinoda A, Suzuki S, Kitada H, Sugishita N, Fukuda Y: Sex differences in acquired cystic disease of the kidney on long-term dialysis. Nephron 39: 336-340, 1985
  • Ishikawa I, Hayama S, Morita K, Nakazawa T, Yokoyama H, Honda R, Satoh K, Kakuma T: Long-term natural history of acquired cystic disease of the kidney. Ther Apher Dial: 14:409-416, 2010
  • Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M, Honda R: Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol 59: 153-159, 2003
  • Ishikawa I: Uremic acquired cystic disease of kidney. Urology 26: 101-108, 1985
  • Ishikawa I: Present status of renal cell carcinoma in dialysis patients:A questionnaire study in 2004 and review of past questionnaires since 1982 (in Japanese with English abstract). J Jpn Soc Dial Ther 38: 1689-1700, 2005
  • Ishikawa I: Present status of acquired cystic disease of the kidney (in Japanese). J Jpn Ass Dial Physicians 23: 179-187, 2008
  • Dunnill MS, Millard PR, Oliver D: Acquired cysti disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J. Clin. Pathol. 30: 868-877, 1977
  • Hughson MD, Hennigar GR, McManus JFA: Atypical cysts, acquired renal cysti disease, and renal cell tumors in end stage dialysis kidneys. Lab. Invest. 42: 475-480, 1980
  • Eble IN, Sauter G, Epstein JI, al. e: WHO classification of tumours. In: Pathology and Genetics:Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press. 2004
  • Ishikawa I, Kovacs G: High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histo-pathology 22: 135-139, 1993
  • Ishikawa I, Shinoda A: Renal adenocarcinoma with or without acquired cysts in chronic hemodialysis patients. Clin Nephrol 20: 321-322, 1983
  • Ishikawa I: Prognosis in dialysis patients complicated with renal cell carcinoma (in Japanese with English abstract). J Jpn Ass Soc Dial Ther 35: 287-293, 2002
  • Ishikawa I: Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002. Nephron Clin Pract 97: c11-16, 2004
  • Ishikawa I, Yuri T, Kitada H, Shinoda A: Regression of acquired cystic disease of the kidney after successful renal transplantation. Am J Nephrol 3: 310-314, 1983
  • Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, Sheikh-Hamad D, Truong LD: Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 29: 443-451, 2005
  • ickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB: Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30: 141-153, 2006
  • Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, Taniguchi S, Nomura I, Inui M, Sugimoto M, Kakehi Y: Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int, 2009
  • Zamin-Khamesh N, Zhai Q, Truong LD: Renal cell carcinoma with calcium oxalate deposition A distinct type of renal cell carcinoma within the spectrum of renal neoplasms associated with acquired cystic kidney disease. Pathology Case Reviews 15: 14-19, 2010
  • Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L: Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 19: 780-787, 2006
  • Pan CC, Chen YJ, Chang LC, Chang YH, Ho DM: Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology 55: 145-153, 2009
  • Japanese Urological Association, Japanese Society of Pathology, Japan-Radiological-Society: General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma (in Japanese). ed 3. Tokyo, Kanehara Syuppan. 1999
  • Ishikawa I: Acquired cysts and cancer of failing kidneys, Cancer and the Kidney, 2nd Ed, Cohen EP, Ed, Oxford University Press, in press. 2010
  • Japanese-Urological-Association: Clinical Practice Guideline for Renal Cell Carcinoma, 2007 ed (in Japanese), Tokyo, Kanehara Syuppan. 1-66, 2007
  • Terasawa Y, Hirota M, Sudo S: Detection of renal cell carcinoma detection by ultrasonography at health check-up (in Japanese). Japanese Association for Cancer Detection and Diagnosis 15: 166-171, 2008
  • Marumo K, Satomi Y, Miyao N, Hasegawa M, Tomita Y, Igarashi T, Onishi T, Nakazawa H, Fukuda M, Ozono S, Terachi T, Tsushima T, Nakamoto T, Kawamura J: The prevalence of renal cell carcinoma: a nation-wide survey in Japan in 1997. Int J Urol 8: 359-365, 2001
  • Ishikawa I, Saito Y, Nakamura M, Takada K, Ishii H, Nakazawa T, Fukuda Y, Asaka M, Tomosugi N, Yuri T: Fifteen-year follow-up of acquired renal cystic disease -a gender difference. Nephron 75: 315-320, 1997
  • Ishikawa I, Honda R, Yamada Y, Kakuma T: Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients. Ther Apher Dial 8: 468-473, 2004
  • Schwarz A, Vatandaslar S, Merkel S, Haller H: Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2: 750-756, 2007
  • Brown EA: Renal tumours in dialysis patients: who should we screen? Nephron Clin Pract 97: c3-4, 2004
  • Sarasin FP, Wong JB, Levey AS, Meyer KB: Screening for acquired cystic kidney disease: a decision analytic perspective. Kidney Int 48: 207-219, 1995
  • Scandling JD: Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening? Clin J Am Soc Nephrol 2: 621-622, 2007
  • Ishikawa I: Uremic acquired renal cystic disease. Natural history and complications . Nephron 58: 257-267, 1991
  • Takebayashi S, Hidai H, Chiba T, Takagi H, Koike S, Matsubara S: Using helical CT to evaluate renal cell carcinoma in patients undergoing hemodialysis: value of early enhanced images. Am. J. Roentgenol. 172: 429-433, 1999
  • Akiyama T, Onoue A: Sonazoid-enhanced ultrasonography: adiagnosis of kidney and prostate disease (in Japanese). Innervision 22: 41-45, 2007
  • Ak I, Can C: F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol 46: 895-899, 2005
  • Ozawa N, Okamura T, Koyama K, Hamazawa Y, Senzaki H, Tanabe S, Ikemoto S, Inoue Y: Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma. Ann Nucl Med 21: 239-243, 2007
  • Shinsako K, Mizuno T, Terada T, Watanabe J, Kamba T, Nakamura E, Ogawa O, Inui KI: Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study. Int J Clin Oncol, 2010
  • Ishikawa I: Cancer in dialysis patients. Cancer and the Kidney, Cohen EP, ed, Oxford University Press, Oxford: 227-247, 2005
Еще
Статья научная
SciUp 2024 © 2024 ©